Diagnosing and managing mild cognitive impairment.

Area of Science:

• Neurology
• Geriatrics
• Psychiatry

Background:

• Dementia diagnoses in England have sharply increased, with an estimated 10-20% prevalence of mild cognitive impairment (MCI) in adults aged 65+.
• MCI is a potential prodrome for dementia, sharing common pathologies and risk factors.
• Depression and MCI are frequently comorbid in the elderly, both independently increasing dementia risk.

Purpose of the Study:

• To highlight the rising prevalence of dementia and MCI in older adults.
• To emphasize the importance of early identification and assessment of MCI.
• To underscore the link between MCI and subsequent dementia development.

Main Methods:

• Review of dementia and MCI prevalence trends.
• Analysis of the relationship between depression, MCI, and dementia risk.
• Discussion of diagnostic criteria and the role of neuropsychological testing.
• Recommendation for referral to specialist memory assessment services.

Main Results:

• MCI prevalence is estimated at 10-20% in adults over 65 and is expected to rise.
• Individuals with MCI have a significantly higher annual conversion rate to dementia (approx. 10%) compared to the general elderly population (1-2%).
• Over 50% of individuals with MCI eventually develop dementia.

Conclusions:

• Early identification of MCI through specialist assessment is vital for timely dementia intervention.
• Accurate history taking from patients and informants is crucial for diagnosing cognitive changes.
• While no specific tests exist for MCI, neuropsychological performance (1-1.5 SD below mean) can indicate impairment.